Skip to product details

Chemical product profile

HONGKUN / PRODUCT DIRECTORY

4-(Chloromethyl)-5-methyl-1,3-dioxol-2-one | CAS 80841-78-7

DMDO-Cl combines a chloromethyl coupling site with an unsaturated cyclic carbonate, supplying the medoxomil ester fragment in a reported olmesartan medoxomil route. The halomethyl form and intact dioxolone ring define the reagent.

CAS80841-78-7
Molecular formulaC5H5ClO3
Molecular weight148.54 g/mol

Product overview

Known as DMDO-Cl or medoxomil chloride, this reagent combines a chloromethyl group with an unsaturated five-membered cyclic carbonate. It supplies the medoxomil ester fragment in olmesartan medoxomil chemistry. The chloro derivative and intact dioxolone ring should remain explicit in the purchase specification.

Chemical identity

Chemical name
4-(Chloromethyl)-5-methyl-1,3-dioxol-2-one
CAS number
80841-78-7
Molecular formula
C5H5ClO3
Molecular weight
148.54 g/mol

Application context

DMDO-Cl introduces the medoxomil ester fragment in a reported olmesartan medoxomil route. The chloromethyl group provides the connection while the dioxolone ring supplies the cyclic-carbonate portion of that ester. Specify the chloro derivative and assess ring-related and halomethyl-related substances for the chosen ester-forming step.

Chemistry and synthetic role

The chloromethyl group provides the ester-forming connection, while the unsaturated five-membered carbonate supplies the ring portion of the medoxomil group. The chloro identity and the intact ring are separate structural features to confirm.

Quality review

Specify the chloro derivative

Retain CAS 80841-78-7 and distinguish corresponding bromo or iodo reagents; a shared DMDO abbreviation is insufficient.

Confirm the carbonate ring

Identification should support the intact dioxolone architecture as well as the chloromethyl substituent.

Separate synthesis and analytical grades

Specify whether the material will be used for ester formation or quantitative analysis. For analytical use, agree characterization and assigned-content requirements.

Preparing a specification

State DMDO-Cl, the exact CAS and the required chloromethyl cyclic carbonate structure. Agree assay, chromatographic related-substance reporting and any application-specific criteria for the selected esterification process. Distinguish a process reagent request from an analytical-reference enquiry before setting documentation requirements.

Packaging and storage

Agree packaging, net weight and transport arrangements for the selected grade, quantity and destination. Confirm storage and handling conditions using the current SDS for the proposed material.

Documentation

Request identity data, the proposed assay method, a batch COA and current SDS. Confirm whether a chromatogram addressing relevant halomethyl and ring-related compounds is available. For reference use, ask separately about content assignment and traceability.

Procurement questions

Is DMDO-Cl olmesartan itself?

No. It is a reagent associated with introducing the medoxomil ester fragment in a published route.

Why retain medoxomil in the application name?

It identifies the prodrug ester; olmesartan alone refers to a different chemical form.

Which halomethyl form should the order specify?

Specify the chloromethyl reagent, CAS 80841-78-7, and its complete dioxolone structure. The corresponding bromo and iodo compounds have different identities.

Technical sources
  1. PubChem CID 9855518 — structure propertiesPubChem / NCBI
  2. PubChem CID 9855518 — CAS and synonymsPubChem / NCBI
  3. 4-Chloromethyl-5-methyl-1,3-dioxol-2-one, C1882TCI
  4. WO2006029056A1 — Preparation of olmesartan medoxomilPatent applicant via Google Patents